(Q44157159)

30 November 2017

title

Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up (English)

1 reference

30 November 2017

0 references

1 reference

pemphigus vulgaris

1 reference

Aberer W

1

1 reference

30 November 2017

Wolff-Schreiner EC

series ordinal

2

1 reference

30 November 2017

Stingl G

series ordinal

3

1 reference

30 November 2017

Wolff K

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

Journal of the American Academy of Dermatology

30 November 2017

published in

1 reference

30 November 2017

volume

16

1 reference

30 November 2017

issue

3 Pt 1

1 reference

30 November 2017

page(s)

527-533

1 reference

Treatment of pemphigus with corticosteroids; study of fifty-two patients

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Corticosteroid treatment of pemphigus. Experience with fifty cases over a period of ten years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Treatment in bullous diseases with corticosteroid drugs and corticotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

International mortality from bullous diseases since 1950.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Pemphigus vulgaris successfully treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Treatment of Pemphigus Vulgaris With Methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Immunosuppressants in the treatment of pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Treatment of pemphigus and pemphigoid with azathioprine.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Azathioprine for pemphigus and pemphigoid--a 4 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Use of cytotoxic drugs in dermatologic diseases. II.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Cytotoxic drugs in treatment of nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Pemphigus and pemphigoid. A review of the advances made since 1964.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Plasma exchange in pemphigus. Uncontrolled study of ten patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Effects of cyclosporin on bullous pemphigoid and pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Long-term maintenance therapy with azathioprine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Risk of cancer in renal-transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Oncogenicity of immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

1 reference

7 January 2021

The events leading to the death of patients with pemphigus and pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970069-3

7 January 2021

10.1016/S0190-9622(87)70069-3

Identifiers

DOI

1 reference

30 November 2017

1 reference